Activators of the pyruvate kinase M2 (PKM2) are currently attracting significant interest as potential anticancer therapies. They may achieve a novel antiproliferation response in cancer cells through modulation of the classic 'Warburg effect' characteristic of aberrant metabolism. In this Letter, we describe the optimization of a weakly active screening hit to a structurally novel series of small molecule 3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as potent PKM2 activators.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2013.12.028 | DOI Listing |
Publication Analysis
Top Keywords
pyruvate kinase
8
kinase pkm2
8
pkm2 activators
8
discovery 3-trifluoromethyl-1h-pyrazole-5-carboxamide
4
3-trifluoromethyl-1h-pyrazole-5-carboxamide activators
4
activators isoform
4
isoform pyruvate
4
activators pyruvate
4
pkm2 currently
4
currently attracting
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!